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Abstract
Background: This study aimed to measure the income-related inequalities and inequities - the inequalities that
remain after accounting for differences in health need - in expenditure on fully publicly covered (hospital and
ambulatory) and partially publicly covered (prescription drugs) services for those in their last year of life in the
province of British Columbia (B.C.), Canada. We focused on a decedent population for three reasons: to minimize
unmeasured need differences among our cohort and therefore isolate income effects; to explore inequities for a
high-spending window of health care use; and, because previous studies have found conflicting relationships
between income and decedent health care spending, to further quantify this relationship.
Methods: We used linked administrative databases to describe spending on health services by income for all
58,820 deaths of B.C. residents 65 and older from 2004 to 2006. Regression analyses examined the association
between income and health care spending, adjusting for age, sex, health status, cause of death, and other relevant
factors. We then used concentration indexes to measure both inequalities and inequities separately for three key
types of services. Analyses were also run separately for men and women.
Results: On average, per capita expenditure on acute health care in the last year of life was $20,705 (CDN2006). In
need-adjusted regression analyses, we found decedents in the highest income quintile had 11% lower hospital
expenditures, 15% higher specialist expenditures and 23% higher prescription drug expenditures than decedents in
the lowest income quintile. Concentration index analysis suggested that spending for all types of care was
concentrated among those with higher income before adjusting for need. Need-adjusted equity results mirrored
regression findings and suggested patterns of inequities that were more pronounced among male decedents than
females.
Conclusions: Despite the universal health care system in B.C., we found patterns of inequity in spending by
income in the last year of life, even for fully publicly covered services. These results, parallel to relationships
between income and spending from previous studies of the B.C. population, suggest persistent income-related
inequities in the health care Canadians receive throughout their lives.
Background
Equity in access to health care, or equal access to care
for those with equal need, has long been a concern
among health services researchers and is a primary
motivation for universal health insurance systems.
Because use of and spending on health care are largely
influenced by need for care, and health status varies by
income [1,2], differences by income in expenditure on
health care, or inequalities in spending, are not necessa-
rily problematic. However, inequalities that remain after
accounting for differences in need, or inequities in use
of health care, signal potential inconsistencies between
actual health care use or access to care and policy ideals.
Previous research has found that income-related dif-
ferences in the use of health services, both inequalities
and inequities, appear to exist in countries with (e.g.
Canada and most countries in Europe) and without (e.g.
the U.S.) universal health coverage [3]. Recent studies
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for differences in need using self-reported health status
(usually measured on a five-point scale from excellent to
poor) along with either self-assessed disease burden or
activity limitations have found evidence of significant
inequities across many health care services [4-6]. For
example, a study based on 1998-2001 non-elderly
respondents to the U.S. National Health Interview Sur-
vey found use of ambulatory care to be inequitable, with
those of higher income using more services than need
would predict [4]. In comparing use of physicians across
12 European countries using pan-European survey data,
van Doorslaer et al. (2004) found pro-poor inequities in
visits to GPs and pro-rich inequities in visits to specia-
lists in virtually all countries [5]. For Canada, using data
from the 2003 wave of the Canadian Community Health
Survey (CCHS), Allin (2008) found pro-rich inequities
in specialist visits, and for probability of a visit to a GP,
and pro-poor inequities in inpatient care for Canada,
but no evidence of income inequities in total visits to
GPs or for inpatient care separately for the province of
B.C. [7]. A recent study using administrative claims
databases for the full population of B.C., which used
diagnosis code based case-mix tools to adjust for health
status, corroborated the CCHS-based findings of pro-
rich inequities in specialist care, but found pro-poor
inequities in GP visits and inpatient care [8]. While the
relationship between income and prescription drug use
has been studied extensively, little work has been done
to directly measure inequities. In sum, while there
appears to be some consensus regarding pro-rich
inequities for specialist visits, the trends in inequity find-
ings for other acute care services, even those specific to
B.C., are less clear.
Reviewers and authors of past studies of equity in
health care argue that a key methodological limitation
in constructing measures of inequity lies in the difficulty
in adequately controlling for variations in need, both in
survey and administrative data based studies [4,8,9]. The
inability to properly measure and control for differences
in need for health care could imply bias in previous
measures of inequity.
We aimed to measure and compare income-related
inequities in the use of medical services, hospital care,
and prescription drugs in B.C. in the last year of life.
We focused on end-of-life care for a cohort of seniors
(age 65 and older) as this allowed for much greater
need standardization than the research that has exam-
ined the entire population. End-of-life cohorts have
been used by Wennberg, Fisher and colleagues to help
reduce bias in the measurement of regional variations in
health services use and cost [10-12]. As such, they also
appear to be good candidates for investigating socioeco-
nomic disparities. As well, this is an important window
of health care use, and of increasing policy importance
as baby-boomer populations in Canada and other devel-
oped countries approach old age and policies surround-
ing end-of-life care gain prominence [13].
Previous studies of income-related differences in use
of health care at end-of-life have found mixed results.
Studies of U.S. Medicare populations have found weak
negative relationships between area-level income and
health care spending [14-16], while studies of Swiss and
Swedish residents found spending on health care at end
o fl i f et oi n c r e a s ew i t hh o u s e hold-level income [17,18].
Thus, we also aimed to further explore the end-of-life
spending and household income relationship by examin-
ing all forms of acute health care spending together and
separately by type, among decedents 65 and older.
As supplementary analyses, we performed sex-
disaggregated regressions and computed sex-specific
measures of inequality and inequity. We explored the
relationship between income and health services use
separately by sex at end-of-life because women and
men, on average, tend to use different levels of health
care throughout the life course and die at different ages
and of different causes. Thus, we aimed to investigate
whether income-related inequities in health services
spending also varied by sex.
We used linked administrative databases to study the
income-related inequities in spending on four main
facets of care: hospital care, general practitioner services,
specialist services, and prescription drugs. In our analy-
sis, we controlled for age, cause of death, sex, area of
residence, and clinical complexity using standard health
equity measures that facilitated comparison to previous
equity studies from Canada, the U.S. and Europe.
Methods
Data
With permissions from relevant data stewards at the
B.C. Ministry of Health Services and the College of
Pharmacists of B.C., we obtained de-identified linked
health data from Population Data B.C. and B.C. Pharma-
Net [19]. These databases cover all B.C. residents except
those whose health care (and therefore health data) is
under federal jurisdiction: status Indians, military per-
sonnel, and the Royal Canadian Mounted Police (under
5% of the total population). For all other individuals, the
datasets contain demographic information, records of all
non-emergency hospital admissions, records of all fee-
for-service medical visits (general and specialist care),
and all prescriptions filled outside of acute care hospitals
(regardless of payer). All residents of B.C. receive uni-
versal, first-dollar public insurance for hospital care and
for general and specialist medical services. Prescription
drugs for B.C. residents are covered through a universal
public drug plan with income-based deductibles, private
Cunningham et al. International Journal for Equity in Health 2011, 10:12
http://www.equityhealthj.com/content/10/1/12
Page 2 of 9employer or individually-sponsored insurance, and out-
of-pocket payments (private payments represent
approximately 55% of total drug spending in B.C.) [20].
Ethics approval for this study was obtained from the
Behavioural Research Ethics Board at the University of
British Columbia.
Cohort
To define our cohort of decedents, we retrospectively
identified deaths in the calendar years 2004, 2005, and
2006 using vital statistics data. We excluded deaths for
those who were under 65 to further minimize the unob-
served health differences within our decedent cohort.
For the same reason, we excluded those who died of
external causes, including accidents and suicides. We
also excluded from our analysis decedents who did not
live in B.C. for at least 275 days in the year before death
to minimize misclassification bias relating to unobserved
use and unmeasured health status. Finally, to reduce the
extent to which use of medical services is undercounted,
we excluded residents of local health areas wherein
greater than 30% of all medical services are provided
non-fee-for-service, and therefore fall outside of our
dataset (representing ~0.5% of all deaths). Our final
cohort included 58,820 decedents.
Dates of death in our datasets contained only year and
month for privacy reasons. We therefore defined the
‘year’ prior to death to include the month of death plus
the 12 preceding months.
Variables
Our analysis focused on the amount of health care
resources used, which we measured in terms of total
cost of acute care services. For the year prior to each
subject’s death, we calculated the cost of non-emergency
hospital care, fee-for-service care from general practi-
tioners, fee-for-service care from specialist physicians,
and prescriptions filled outside of acute care hospitals.
Costs for prescription drugs were included regardless of
coverage and included the pharmacist fees associated
with each prescription filled. Costs for pharmaceuticals
and fee-for-service medical care were based on actual
fees and prices paid. However, because hospitals are
block funded in Canada, the cost of hospital care was
computed using standard costing methods for cases of
differing resource intensity [8,21,22]. We ran analyses
for five dependent variables: total acute costs (the sum
of hospital, medical and prescription drug expenditures),
and separately hospital, fee-for-service general practi-
tioner, fee-for-service specialist care, and prescription
drugs. All costs were inflation-adjusted to 2006
Canadian dollars.
Our independent variable of primary interest was
household income percentile. For approximately 95% of
our cohort, our income percentiles were based on
household-specific income data for 2003 that was vali-
d a t e du s i n gC a n a d aR e v e n u eA g e n c yd a t ab yt h eB . C .
Ministry of Health Services. For the remaining sample,
our income percentiles were based on average incomes
reported in year-2003 tax returns by households across
Census Dissemination Areas (comprising 400-700 per-
sons) [23]. For regression analyses, we created dummy
variables for each income quintile in order to allow for
non-linearities in relationships between income and
dependent variables. Incomes were re-grouped into sex-
specific percentiles and quintiles for sex disaggregated
analyses.
Based on diagnosis codes in medical and hospital
records for the last year of life, we used Aggregated
Diagnostic Groups (ADGs) of the Johns Hopkins ACG
®
Case-Mix system to measure each decedent’s general
clinical complexity [24]. Each hospital record contains
up to 25 diagnosis codes and each record of a fee-for-
service medical visit contains one diagnosis code. The
ACG system maps these diagnoses into 32 ADGs of
varying clinical severity. Groups with the highest
expected resource use are called major ADGs. We
counted separately the number of major ADGs and the
number of non-major ADGs for each individual.
We controlled for age at death using dummy variables
representing 5-year age bands (e.g. 65 to 69), with a
combined group for those 100 and older, as we have
previously identified non-linear relationships between
a g ea n du s eo fh e a l t hc a r e[ 2 5 , 2 6 ] .W ea c c o u n t e df o r
whether an individual resided in a long term care facility
or received palliative care based on program indicators
from the drug claims database. We also controlled for
the effects of urban/rural differences in resource avail-
ability and care use; to be considered urban, the major-
ity of residents of the local area had to have resided in
the dominant city (comprised of at least 25,000 resi-
dents). Finally, because cancer deaths are likely to result
in distinct patterns of end-of-life care [27], and cancer
and cardiovascular-related deaths account for the large
majority of deaths and vary (seemingly symmetrically)
with income within our sample, we controlled for
cancer cause of death using vital statistics records.
Because pooled decedent data (2004-2006) were used in
order to increase sample size, we also controlled for
year of death in all analyses.
Statistical Analysis
In our regression analyses, we used generalized linear
methods (GLM) using the log link and the gamma dis-
tribution, selected using standard methods for health
cost data [28,29]. GLM allowed us to relax the strict
normal error assumption of linear least squares regres-
sion (which right-skewed, zero clustered health
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tions of retransforming estimates to eliminate potential
bias in non-linear or log-transformed least squares
[30,31]. Because nearly our entire cohort had positive
expenditures for the services examined, we used one-
step GLM models.
We used concentration indexes (CIs) to measure the
differences in spending on services by type, and horizon-
tal inequity (HI) index measures to quantify inequities in
spending unrelated to need [32,33]. In the context of the
present study, a CI summarizes the extent to which the
distribution of health care resources (costs) differs from
uniformity across income groups (percentiles). A CI will
be zero when resources are distributed equally across
income groups, negative when resources are concen-
trated among those with low incomes, and positive
when resources are concentrated among those with high
incomes.
S o m eo ft h er e s o u r c ec o n c e n t r a t i o nc a p t u r e db yt h e
CI may reflect income-related inequalities in health
need. A measure of inequity (as opposed to inequality)
must account for income-related differences in health
status and thereby quantify how observed patterns of
care deviate from the principle of ‘equal treatment for
equal need’ [5]. To construct such a measure, the HI
index [32], we first used regression analysis to predict
the amount of health care we would have expected each
individual to receive based on her or his age, sex, health
status, and cause of death, holding other variables
including income, nursing home residence, and region
of residence at the sample mean. The predicted values
from this analysis are estimates of the amount of health
care resources that a decedent would have received if
treated the same as the average person with the same
need profile [33]. We used these values to compute
need-predicted concentration indexes for each category
of health spending.
We then computed the HI for expenditure for each
service as the difference between the observed inequality
in spending and the inequality in spending that would
be predicted based on need. The HI thus measures how
much of the observed inequality in the distribution of
spending on health care is left unaccounted for by the
unequal distribution of health-related need. The HI
measure will be zero when health care spending is dis-
tributed across incomes in proportion to how health
care need is distributed. A negative (positive) HI means
that health care spending is more concentrated in lower
(higher) income groups than health care need would
predict. One can quantitatively interpret the HI as
roughly the share of expenditure that would need to be
transferred from the half of the distribution with greater
than predicted spending to the other in order for spend-
ing to equitably reflect health need [34]. We reported
both the CI that measures the income-related inequal-
ities in actual health care expenditures and the HI.
While we expected regression and equity analyses to
generate similar findings, we discuss both: regression
findings put our results in the context of previous end-
of-life literature, while equity analyses allowed us to
directly compare the degree of inequity measured, using
HI estimates, to previous equity results.
Results
Table 1 describes our study population by income quintile.
Those with the lowest incomes were older, female, non-
urban dwelling, more likely to live in a residential care
facility, less likely to use the palliative care program, and
had fewer diagnosed conditions than those with the high-
est incomes. Some of these differences by income (e.g., age
and palliative care) are likely to be related to differences in
cause of death: low-income decedents were more likely to
die of cardiovascular and respiratory conditions but less
likely to die of cancer than high-income decedents.
Table 1 also lists rates of use, various use intensity mea-
sures, and mean per capita expenditure by service type.
Use of hospitals, specialist services and prescription drugs
were higher in higher income groups than for those of
lower income, while nearly all decedents visited a general
practitioner, regardless of income. Expenditures for each
t y p eo fs e r v i c ee x a m i n e dw e r eh i g h e ri nt h eh i g h e s t
income group compared to the lowest.
Table 2 lists the adjusted associations between income
quintile and health care spending in the last year of life
for sex-stratified and pooled models (which include sex
as a covariate). These models adjust for age, health sta-
tus, cause of death, use of long term care facilities, rural
residence, and year of death (see the Appendix Table in
Additional file 1 for full regression results). For compar-
ison with previous end-of-life literature, the first column
of results describes total health care spending. For all
costs combined in both the sex-pooled and sex-disag-
gregated models, there was no statistically significant
difference in total health care spending in the last year
of life between the lowest, second lowest and middle
income quintiles after other factors were accounted for.
For women and in the sex-pooled, model total measured
spending on care in the last year of life for those in the
highest two income quintiles was slightly below (by
4-6%) those in the lowest income quintile. For men,
there was no statistically significant difference.
After other factors were accounted for, income gradi-
ents for spending during the last year of life differed sig-
nificantly by type of health care. In sex-pooled results
the gradient for hospital spending was negative whereas
gradients for spending on general practitioner services,
specialist services, and prescription drugs were generally
positive. Because hospital spending represents, on
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year of life, hospital and total spending regressions are
fairly similar. Spending on hospital care was approxi-
mately 10% lower for decedents in the highest two
income quintiles compared to the lowest income
quintile.
In the sex-pooled regression analysis and separately
for men the gradient in spending on general practitioner
services among the last year of life was positive, but
decreasing. Decedents in the middle income quintiles
had 5-6% higher spending than those in the lowest
quintile while decedents in the highest quintile had 2%
higher spending than those in the lowest quintile. The
income gradient for spending on general practitioner
services was not significant for women.
After other factors were accounted for, spending on
specialist medical care and prescription drugs during the
last year of life was more positively correlated with
Table 1 Description of study population, by income quintile
Income quintile
1 (lowest) 2 3 4 5 (highest) Total
N 11,764 11,764 11,764 11,764 11,764 58,820
Died 2004, % 34 (0.44) 34 (0.44) 34 (0.44) 33 (0.43) 31 (0.43) 33 (0.19)
Died 2005, % 33 (0.43) 34 (0.44) 33 (0.43) 32 (0.43) 33 (0.43) 33 (0.19)
Died 2006, % 33 (0.43) 33 (0.43) 34 (0.44) 34 (0.44) 35 (0.44) 34 (0.19)
Female, % 71 (0.42) 63 (0.45) 48 (0.46) 43 (0.46) 38 (0.45) 52 (0.21)
Age at death, mean 83.5 (0.09) 84.1 (0.07) 82.1 (0.07) 81.0 (0.07) 80.4 (0.07) 82.2 (0.03)
Urban resident, % 81 (0.24) 79 (0.25) 78 (0.26) 78 (0.25) 84 (0.20) 80 (0.11)
Major ADGs, mean count 2.6 (0.01) 2.7 (0.01) 2.8 (0.01) 2.8 (0.01) 2.9 (0.01) 2.8 (0.01)
Minor ADGs, mean count 5.8 (0.03) 6.1 (0.03) 6.2 (0.02) 6.2 (0.03) 6.3 (0.02) 6.1 (0.01)
Cancer cause of death, % 20 (0.37) 22 (0.38) 26 (0.41) 29 (0.42) 32 (0.43) 26 (0.18)
Cardiovascular cause of death, % 28 (0.41) 27 (0.41) 25 (0.40) 24 (0.39) 23 (0.39) 25 (0.18)
Respiratory cause of death, % 14 (0.32) 13 (0.31) 13 (0.31) 11 (0.29) 11 (0.29) 12 (0.14)
Residential care, % 28 (0.41) 26 (0.40) 22 (0.38) 20 (0.37) 18 (0.35) 23 (0.17)
Palliative care Rx coverage, % 11 (0.29) 12 (0.30) 15 (0.33) 17 (0.35) 21 (0.37) 15 (0.15)
USE
Hospital, % 68 (0.43) 72 (0.42) 73 (0.41) 73 (0.41) 75 (0.40) 72 (0.18)
General practitioner, % 98 (0.14) 99 (0.10) 99 (0.10) 99 (0.10) 99 (0.09) 99 (0.05)
Specialist physicians, % 92 (0.25) 94 (0.22) 94 (0.21) 95 (0.21) 96 (0.19) 94 (0.10)
Prescription drug, % 86 (0.32) 86 (0.32) 86 (0.32) 88 (0.30) 90 (0.28) 87 (0.14)
Nights in hospital, mean 19 (0.28) 21 (0.29) 21 (0.30) 20 (0.28) 20 (0.29) 20 (0.13)
General practitioner contacts,
mean
24.2 (0.18) 26.4 (0.18) 26.7 (0.18) 26.9 (0.18) 26.8 (0.18) 26.2 (0.08)
Specialist contacts, mean 17.4 (0.24) 19.1 (0.24) 20.9 (0.25) 22.7 (0.26) 25.6 (0.27) 21.1 (0.11)
Count of drug types (ATCL3), mean 8.14 (0.05) 8.38 (0.05) 8.42 (0.05) 8.59 (0.05) 8.91 (0.05) 8.49 (0.02)
Total days of prescriptions,
mean
1428 (11.5) 1460 (11.3) 1442 (11.3) 1428 (11.0) 1447 (10.7) 1441 (5.0)
Number of prescriptions, mean 60 (0.82) 61 (0.83) 54 (0.71) 50 (0.63) 47 (0.59) 54 (0.33)
EXPENDITURES ($2006)
Total 19,063
(238)
20,183
(239)
21,213
(254)
20,870
(243)
22,201
(268)
20,705
(111)
Hospital 15,165
(220)
16,035
(222)
16,787
(236)
16,249
(224)
17,111
(247)
16,269
(103)
General practitioners 949 (7.7) 1,050 (7.9) 1,076 (7.9) 1,071 (7.8) 1,059 (7.6) 1,041 (3.5)
Specialist physicians 1,380
(18.6)
1,460
(18.1)
1,674
(19.9)
1,803
(21.2)
2,072
(23.1)
1,678 (9.1)
Prescription drugs 1,526
(17.1)
1,593
(17.0)
1,639
(17.4)
1,726
(19.4)
1,939
(22.7)
1,685 (8.4)
ADGs = Aggregated Diagnostic Groups.
Standard errors in parentheses.
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larly among men. Spending on specialist care during the
last year of life by males in the highest quintile was 20%
higher than such spending by males in the lowest
income quintile. Similarly, spending on prescription
drugs by high-income men during their last year of life
was approximately 30% higher than prescription drug
spending by men in the lowest income quintile. For
women, spending on specialist medical care and on pre-
scription drugs during the last year of life was signifi-
cantly higher among those in the highest income
quintile compared to those in the lowest income quin-
tile; however, the gradient across income quintiles was
not significant for specialist care and non-linear for pre-
scription drugs.
Table 3 lists the concentration indexes and horizontal
inequity measures for hospital services, general practi-
tioners, specialists and prescription drugs. For the sex-
pooled model, resource use was concentrated in higher
income groups, for all services examined, before
adjusting for need (CI). After adjusting for need, spend-
ing on hospital care and general practitioner services
was disproportionately concentrated in those of lower
income (HI -0.031 and -0.006, respectively). While less
dramatic than the concentration index measures, spend-
ing on specialist services and prescription drugs
remained concentrated in those with higher incomes
(HI 0.034 and 0.033). Across types of care studied, the
degree of measured horizontal inequity in health care
spending was greater for men than women, particularly
for specialist medical care and prescription drugs, which
are disproportionately concentrated in higher income
decedents.
Discussion
Using population-based sources of administrative health
care data, we found evidence of significant inequities in
the need-adjusted distribution of health services at end-
of-life. When health need is accounted for, decedents of
higher income have higher expenditures than those of
Table 2 Regression results: adjusted relationship between income quintile and spending on health services in the last
year of life for a cross-section of British Columbians in their last year of life, 2004-2006
Total Population (n = 58,880)
All services
combined
Hospital
care
General
practitioners
Medical
specialists
Prescription
drugs
Income 1
(reference)
——— — —
Income 2 0.024 0.009 0.050*** 0.040** 0.072***
Income 3 0.006 -0.020 0.061*** 0.055*** 0.073***
Income 4 -0.040** -0.091*** 0.050*** 0.065*** 0.106***
Income 5 -0.037* -0.115*** 0.020* 0.137*** 0.208***
Females (n = 30,087)
All services combined Hospital care General practitioners Medical specialists Prescription drugs
Income 1
(reference)
——— — —
Income 2 -0.014 -0.051 0.005 0.017 0.055**
Income 3 -0.004 -0.030 0.032** 0.033 0.067**
Income 4 -0.058** -0.111** 0.014 0.041 0.030
Income 5 -0.059** -0.132*** -0.009 0.076*** 0.122***
Males (n = 28,013)
All services combined Hospital care General practitioners Medical specialists Prescription drugs
Income 1
(reference)
——— — —
Income 2 0.038 0.022 0.068*** 0.068*** 0.118***
Income 3 0.014 -0.015 0.096*** 0.083*** 0.151***
Income 4 -0.030 -0.096** 0.063*** 0.104*** 0.222***
Income 5 -0.026 -0.116*** 0.022 0.200*** 0.316***
Model adjusted for age, health status, cancer death, year of death, urban dwelling, residential care, and sex (sex-pooled model only). See Additional file 1 for all
regression coefficients.
Regression models are GLM with log link (dependent variables thus modeled as log of expenditure in last year of life).
* p < 0.05, ** p < 0.01, *** p < 0.001.
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hospital services, spending was concentrated in those of
lower income more so than the income distribution of
need would predict. Spending on general practitioners
showed a very small concentration in those of low
income, although regression results highlighted a non-
linear relationship between need-adjusted spending and
income. For all types of services examined, inequities
appeared more pronounced among male decedents than
females.
Results of our regression analyses showing a negative
relationship between income and total acute healthcare
spending at end-of-life are consistent with previous ana-
lyses of total Medicare expenditures for sample decedent
populations [14,15]. Yet, the results for total acute
spending contrast a recent analysis of a full population
of Stockholm decedents which found spending at end-
o f - l i f eo nt h es a m es u i t eo fs e r v i c e st oi n c r e a s ew i t h
income [17]. That analysis did not include detailed
information on individual co-morbidities; our findings of
a negative income relationship for overall end-of-life
spending after need adjustment are largely influenced by
accounting for health status, and allowing for a non-
linear relationship between age at death (which varies
with income) and spending. Sensitivity analyses in which
we omitted health status controls (major and non-major
ADGs) found no significant relationship between
income and total measured health care spending (data
available upon request). By using improved health status
measures combined with full population data and allow-
ing for flexible relationships between health care spend-
ing and covariates, our analysis improves on these
previous end-of-life studies.
Using an end-of-life cohort for our equity analysis, our
measures of horizontal inequity for hospital and medical
services care were smaller than but similar to measures
from survey-based studies of full European and North
American populations [3,5,6]. Our results concerning
inequities in end-of-life spending on hospital, general
practitioner and specialist care are of the same direction,
although generally larger, than those found using
administrative data for the full population (including
non-decedents) of B.C. in 2002 [8]. Results for specialist
services were similar to those found using survey data
from 2003. Hospital care results in that study were not
significant for B.C.; however they found pro-poor
inequities in hospital care for Canada as a whole [7].
While small sample sizes might have limited province-
specific results in that study (their B.C. sample was
12,367), point estimates of HI suggested pro-rich inequi-
ties in use of inpatient care as measured by total nights
in hospital.
Previous research that compared horizontal inequity
in universally covered services (including hospital, GP
and specialist services) to partially covered services
(including pharmaceuticals) in Denmark found statisti-
cally significant inequities only for partially covered ser-
vices, with amount spent concentrated in those with
higher incomes [35]. Point estimates of horizontal
inequity for hospital and specialist services, while insig-
nificant, were similar in size to ours; however, the HI
for pharmaceuticals was three times as large in the Dan-
ish study. Such differences are likely related to differ-
ences in public drug plans: in B.C., public coverage is
based on household income and the amount spent on
pharmaceuticals, while in Denmark public reimburse-
ment is related only to the absolute amount spent on
pharmaceuticals.
While a higher concentration of spending on specia-
lists and pharmaceuticals by higher income decedents is
likely not surprising, given other socio-economic differ-
ences that may make accessing such services easier for
those of higher income, including education, private
support systems, employer-based insurance and relative
affordability of any out-of-pocket payments, it is perhaps
more surprising to find the reverse income gradient for
hospital services. Some of this may be substitution of
hospital care for other health services. As research from
the US suggests, low income is associated with a higher
number of ambulatory care-sensitive condition admis-
sions at the hospital level for Veterans Affairs patients
[36]. Further research focusing on hospital care could
illuminate how use of varying types and different
Table 3 Inequality and inequity in spending on hospital,
general practitioners, specialists, and pharmaceuticals at
end-of-life
Total Population
Inequality (CI) Inequity (HI)
Hospital 0.017 -0.031
General practitioner 0.017 -0.006
Specialist physician 0.078 0.024
Prescription drugs 0.044 0.033
Females
Inequality (CI) Inequity (HI)
Hospital 0.006 -0.028
General Practitioner 0.009 -0.006
Specialist physician 0.062 0.022
Prescription drugs 0.040 0.020
Males
Inequality (CI) Inequity (HI)
Hospital 0.002 -0.031
General practitioner 0.015 -0.008
Specialist physician 0.057 0.030
Prescription drugs 0.065 0.055
Bold values statistically significant at p < 0.05.
CI = Concentration Index, HI = Horizontal Inequity.
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butes to income-related inequities in spending.
Our results should be interpreted within the context
of several notable limitations. First, we lack informa-
tion on continuing care, whether provided in skilled
nursing facilities or at home, both of which may
substitute for some forms of hospital care at the end-
of-life. Including publicly funded care would have
potentially steepened the income gradient found in
analysis of combined health services, as residence in
care homes appears higher for lower income decedents
(see Table 1); however, previous research suggests an
unclear relationship between income and continuing
care use [37-39].
A second limitation of our analysis relates to our
income measure. Ideally, we would have had income
values for each decedent for the year preceding their
death. However, given the stability of income over time
and the short period of our analysis, misclassification
from using 2003 incomes was likely minimal.
We analysed spending on each health service, which
acts as a proxy of resource use intensity, but does not
measure the quality of service. A quality adjustment to
dollars spent might have produced a stronger income
gradient in medical services. A study of home visits by
family practitioners to end-of-life cancer patients in
Nova Scotia found that while nearly all patients had
contact with a family practitioner in their last six
months of life, those living in lower income areas were
less likely to receive home visits compared to high and
middle income area residents [40]. Quality adjustments
may also have mitigated income findings if those receiv-
ing more care in terms of dollars spent were somehow
getting care of lower quality or excessive levels of care.
In other words, because we lack a measure of “optimal”
or “appropriate” care, our findings of a pro-poor distri-
bution in hospital spending at end-of-life may reflect
some overuse of such care by persons with low incomes.
Similarly, the pro-rich findings with respect to specialist
medical care and prescription drugs might represent
over-provision of such care to wealthier patients. How-
ever, a recent study of Canadian populations suggests
that including a measure of unmet need in equity ana-
lyses, allowing for heterogeneity in the level of optimal
care, did not affect equity findings [41]. The robustness
of inequity findings suggests that identifying potential
systemic reasons for the observed patterns of inequity is
important in designing policies to address these
patterns.
Conclusions
This paper is the first to our knowledge to compara-
tively measure the level of inequity in health care spend-
ing for decedents across various types of care using
standard health equity measures. It is also the first to
comparatively examine inequities in spending by type
separately for men and women decedents. We found
higher spending on specialist services and pharmaceuti-
cals at end-of-life for those with higher incomes, which
mirrors pro-rich patterns of spending and use in non-
decedent populations. This suggests continuity of
income inequities in health care use over the life course
and the potential lock-in of care inequities over time.
The concentration of hospital spending among those of
lower incomes may be reflective of trade-offs in care
between specialist services, general practitioners, and
hospitals, or substitution of hospital care for home-
based health and social care [42], that may signal ineffi-
ciencies. While our measures of inequity, put in interna-
tional context, are relatively small, findings of inequities
in a population for which unobserved health differences
are minimized confirm the presence of systemic inequi-
ties in access to care.
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